TussiCaps® Extended-Release Capsules
Rx only CIII
TussiCaps Extended-Release Capsules are comprised of an antitussive and antihistamine formulation indicated for the relief of cough and upper respiratory symptoms associated with colds or allergies. TussiCaps is available in full-strength (TussiCaps 10/8) and half-strength (TussiCaps 5/4) Capsules. TussiCaps Capsules provide 12 hours of relief from a single dose thus allowing for twice-daily dosing that can enhance both patient convenience and compliance. The unique capsule dosage form helps assure dosing accuracy, which may be a challenge when dosing liquid cough preparations. The capsule also avoids the unpleasant taste and messiness so often associated with cough syrups. TussiCaps are also easily portable.
Usual Adult Dose: One full-strength capsule (TussiCaps 10/8) every 12 hours. Do not exceed two (2) capsules in 24 hours.
Children 6-11 years: One half-strength capsule (TussiCaps 5/4) every 12 hours. Do not exceed two (2) capsules in 24 hours. TussiCaps 5/4 half-strength capsules may also benefit elderly patients which require less than a ful-strength adult dosage.
See TussiCaps Product Labeling for additional product and patient information.
Lodrane® 24 – Lodrane® 24D Update
On March 3, 2011 the FDA published a notice that some 500 long marketed and widely used cough, cold, and allergy products would have to cease distribution after August 31, 2011. Though many of these products had been available for more than 40 years and their ingredients recognized by the FDA as safe and effective, many had not been the subject of the current formal approval process. The extended release Lodrane® products (Lodrane® 24, Lodrane® 24 D, and Lodrane® 12D) were affected by this notice.
While ECR began additional work on the Lodrane® extended release products in 2010, the above notice did not provide time to complete the necessary work, submit this to the FDA, and secure the approvals in order to continue the marketing these products. ECR continues to proceed with the work to formalize approvals but at this time we cannot project when such may occur. We regret that this circumstance has left many patients without the therapeutic alternatives previously available.
In the interim, we have formulated an immediate release Lodrane® D Capsule which provides the same ingredients present in Lodrane® 24 D extended release capsule. Please see Lodrane® D Capsules in the Products section of this website for additional product and dosing information.
Lodrane® D Capsules
Lodrane® D Capsules are comprised of an immediate release formulation of an antihistamine (brompheniramine maleate) and decongestant (pseudoephedrine HCl). Lodrane® D is indicated for the relief of symptoms associated with allergic rhinitis, including runny nose, sneezing, itching of the nose or throat, itchy watery eyes, and nasal congestion due to the common cold, hay fever, or other upper respiratory allergies. Lodrane® D promotes nasal and sinus drainage.
Lodrane® D Capsules
Adults and Children over 12 years: One capsule every 4-6 hours, not to exceed 4 capsules in 24 hours.
Please see Lodrane® D Capsules Product Labeling for additional information. Please consult your physician if you have questions regarding your use or potential use of this product.